Focus of the Week

October 18, 2019
The change to the public charge rule has had a negative impact on immigrant patients, who are disenrolling or declining to enroll in Medicaid and are delaying or avoiding care, according to a survey of community health centers.
October 17, 2019
The study found that, on average, it took nearly 2 months or longer for patients of color to receive immunomodulatory drugs such as lenalidomide and/or proteasome inhibitors such as bortezomib and carfilzomib. The use of these therapies has more than doubled survival of patients with multiple myeloma within the past decade.
October 16, 2019
African Americans who report high levels of chronic stress were shown to be at a heightened risk of developing high blood pressure, or hypertension, with specific stressors such as discrimination and socioeconomic status serving as possible catalysts, according to study findings.
October 15, 2019
A medical affairs official with Janssen said physicians may not bring up the option of a long-acting injectable for fear of disrupting the doctor-patient relationship.
October 14, 2019
Patients on Medicare with metastatic breast cancer who receive treatment that is discordant with NCCN guidelines bear a greater burden of patient cost responsibility than patients who do receive care according to treatment guidelines.
October 11, 2019
Randomized controlled trials (RCTs) may be considered the gold standard for generating clinical evidence, but there is growing interest in using real-world evidence. However, only a small portion of clinical trials could be replicated in the real world, according to a new study published in JAMA Network Open.
October 10, 2019
In an effort to educate clinicians about the issue of forcing patients in pain to suddenly halt opioid use, HHS released a guide that emphasizes patient-centered care and recommends against a rapid taper or stopping opioids all at once, while a patient living with chronic pain both welcomed the guide and expressed concern.
October 09, 2019
Long term e-cigarette impact on humans remains unknown, although studies on mice suggest potentially harmful consequences for users.
October 07, 2019
The mechanism studied affects a broad range of physiological responses and is now the focus of intense study by the pharmaceutical industry. 
October 04, 2019
While current guidelines recommend that only women with breast cancer who have a family history or who meet clinical criteria undergo genetic testing, a new cost-effectiveness analysis suggests that genetic testing should be expanded to all women with breast cancer.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.